New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 9, 2012
12:35 EDTMMM, DGXQuest Diagnostics unit, 3M say FDA gives clearance for Simplexa test
Focus Diagnostics, a business of Quest Diagnostics (DGX), and 3M (MMM) announced that the U.S. Food and Drug Administration has provided 510(k) clearance and CLIA moderate-complexity categorization to the Simplexa Flu A/B & RSV Direct test on the 3M Integrated Cycler. The new test aids in the qualitative detection and differentiation of RNA of influenza A and B viruses and respiratory syncytial virus, common causes of respiratory illness. The Simplexa Flu A/B & RSV Direct is now available in the United States. It was CE marked for distribution in Europe in 2011.
News For DGX;MMM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
10:00 EDTDGXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:51 EDTDGXQuest Diagnostics upgraded to Buy at Canaccord
Subscribe for More Information
07:18 EDTMMMJPMorgan to hold a conference
Subscribe for More Information
06:36 EDTDGXQuest Diagnostics upgraded to Buy from Hold at Canaccord
Subscribe for More Information
March 2, 2015
10:00 EDTDGXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:56 EDTDGXQuest Diagnostics initiated with an Equal Weight at Barclays
Subscribe for More Information
February 26, 2015
10:00 EDTDGXOn The Fly: Analyst Downgrade SummaryStarz
Subscribe for More Information
07:24 EDTDGXQuest Diagnostics downgraded to Buy from Conviction Buy at Goldman
Goldman removed Quest Diagnostics (DGX) from the Conviction Buy List and added LabCorp (LH) to the list. The firm believes LabCorp will have higher average organic growth and earnings growth, and views its valuation as more attractive. The firm rates Quest Diagnostics a Buy with a $77 price target.
February 23, 2015
14:44 EDTMMM3M confirms agreement to acquire Polyporeís Separations Media business for $1B
3M (MMM) announced that it has entered into a definitive agreement with Polypore International (PPO) to acquire the assets and liabilities associated with Polyporeís Separations Media business for a total purchase price of $1B. Polyporeís Separations Media business is a leading provider of microporous membranes and modules for filtration in the life sciences, industrial and specialty segments with trailing 12-month sales of $210M as of Sept. 27, 2014. Separately, Asahi Kasei has announced that it has entered into a definitive merger agreement to acquire Polyporeís Energy Storage business. Both transactions are subject to regulatory approvals and customary closing conditions. In addition, both transactions are conditioned on 3Mís transaction with Polypore closing immediately prior to the closing of Asahi Kaseiís transaction with Polypore.
12:21 EDTMMMOn The Fly: Midday Wrap
Subscribe for More Information
09:59 EDTDGXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Antofagasta (ANFGY) downgraded to Sell from Neutral at Goldman... Arch Coal (ACI) downgraded to Sell from Buy at Argus... BHP Billiton (BHP) downgraded to Equal Weight from Overweight at Morgan Stanley... Beazer Homes (BZH) downgraded to Neutral from Buy at Compass Point... Boeing (BA) downgraded to Sell from Neutral at Goldman... Century Communities (CCS) downgraded to Neutral from Overweight at JPMorgan... CyberArk (CYBR) downgraded to Underweight from Neutral at JPMorgan... DirecTV (DTV) downgraded to Hold from Buy at Brean Capital... Enerplus (ERF) downgraded to Hold from Buy at Desjardins... Fiserv (FISV) downgraded to Neutral from Buy at Monness Crespi... GP Strategies (GPX) downgraded to Neutral from Buy at B. Riley... Interactive Brokers (IBKR) downgraded to Market Perform at Keefe Bruyette... MRC Global (MRC) downgraded at BB&T... Precision Castparts (PCP) downgraded to Neutral from Buy at Goldman... Quest Diagnostics (DGX) downgraded at BofA/Merrill... Rio Tinto (RIO) downgraded to Equal Weight from Overweight at Morgan Stanley... Roth Capital downgraded Spectrum (SPPI) on court case loss... Royal Dutch Shell (RDS.A) downgraded to Sector Perform from Outperform at Howard Weil... Ryland Group (RYL) downgraded to Neutral from Buy at Compass Point... Salix (SLXP) downgraded to Market Perform from Outperform at Leerink... Standard Pacific (SPF) downgraded to Neutral from Buy at Compass Point... Superior Energy (SPN) downgraded to Neutral from Outperform at Credit Suisse... Transocean (RIG) downgraded to Negative from Neutral at Susquehanna... Vale (VALE) downgraded to Equal Weight from Overweight at Morgan Stanley.
08:18 EDTDGXQuest Diagnostics downgraded at BofA/Merrill
Subscribe for More Information
06:24 EDTDGXQuest Diagnostics downgraded to Underperform from Neutral at BofA/Merrill
05:34 EDTMMM3M expects acquisition of Polypore business to be dilutive to earnings
Subscribe for More Information
05:31 EDTMMM3M acquires Polypore's Separatoins Media Segment for $1B
As an integrated step in Polypore's (PPO) sale to Asahi Kasei for $60.50, immediately prior the transaction, 3M (MMM) will acquire the assets of Polypore's Separations Media segment for approximately $1band Asahi Kasei will receive the cash proceeds from the asset sale. The definitive agreements require that the sale of the Polypore and the integrated sale of the Separations Media segment close after closing conditions for both transactions have been satisfied and that the closings of the transactions are conditioned upon one another.
05:29 EDTMMMPolypore agrees to sell company for $60.50 per share
Subscribe for More Information
February 20, 2015
07:08 EDTDGXAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 19, 2015
10:01 EDTMMM3M acquires health care products manufacturer Ivera Medical
3M announced that it has entered into a definitive agreement to acquire Ivera Medical, a manufacturer of health care products that disinfect and protect devices used for access into a patientís bloodstream. Terms of the transaction were not disclosed. Ivera employs approximately 60 people and has annual sales of approximately $30M. The transaction is expected to close in the first half of 2015. On a GAAP reported basis, 3M estimates the acquisition to be neutral to earnings in the first 12 months following completion of the transaction.
February 18, 2015
07:07 EDTMMMBarclays to hold a conference
Industrial Select Conference is being held in Miami on February 18-19.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use